1 / 28

“The Coming RFID Revolution in Individual Dose Drug Packaging”

“The Coming RFID Revolution in Individual Dose Drug Packaging”. Mark A. Niemiec Global Packaging Innovations & DDMS Holdings June 6, 2005. “We need new systems to monitor the use of drugs.” Explains acting Deputy Commissioner, FDA, Janet Woodcock

ethan
Télécharger la présentation

“The Coming RFID Revolution in Individual Dose Drug Packaging”

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. “The Coming RFID Revolution in Individual Dose Drug Packaging” Mark A. Niemiec Global Packaging Innovations & DDMS Holdings June 6, 2005

  2. “We need new systems to monitor the use of drugs.” Explains acting Deputy Commissioner, FDA, Janet Woodcock Source: 2/7/05 Business Week “The Vioxx Fallout on the Hill” FDA Under Pressure! DDMS,LLC

  3. RFID Provides Opportunity For New System DDMS,LLC

  4. Drug Delivery Management System • Patented DDMS technology is being developed that will detect when a pill is removed from the unit dose drug package • “Real Time” monitoring using RFID technology • Additional “security circuit” to detect when pill is removed • Portable or fixed reader • Environmental sensors DDMS,LLC

  5. Pharmaceutical Industry Facing Major Issues • Reduce clinical trial cost • Eliminate mistakes in hospitals • Implement track’n trace • Improve patient compliance DDMS/RFID packaging can provide solutions to all of these issues DDMS,LLC

  6. Clinical Trial Cost Factors • Qualified patients - hard to find • Acquiring the data - manually • Accuracy of data - patient honesty • Non-Compliant patients - bias data DDMS,LLC

  7. Electronic Compliance Packaging Making Inroads Into Clinical Trials • Two electronic compliance packaging systems already being tested: • cerepak – MeadWestvaco • Medic – Information Mediary Corp. • Both require downloading compliance data at later time DDMS,LLC

  8. DDMS Can Reduce Clinical Trial Cost • DDMS provides “real time” patient monitoring • Electronic compliance data recording • More cost effective • Allows for intervention • Improves quality of data DDMS,LLC

  9. Pharmaceutical Industry Facing Major Issues • Reduce clinical trial cost • Eliminate mistakes in hospitals • Implement track’n trace • Improve patient compliance DDMS/RFID packaging can provide solutions to all of these issues DDMS,LLC

  10. Hospital Safety Major Issue • ’99 IOM Study – 98,000 deaths due to mistakes • Increases cost • FDA forced to take action • Have you been personally affected by mistakes? DDMS,LLC

  11. FDA Addressing Hospitals Mistakes • Requiring “bar code” technology for drugs • Seen as first step • Labor intensive • Line-of-site required • Limited information • FDA aware of RFID potential DDMS,LLC

  12. RFID Already Having An Impact In Hospitals • Asset management systems available • Exaver: Wi-Fi + RFID • Mobile Aspects: “smart cabinet” • Closed loop modular supply systems • RFID drug packaging logical next step DDMS,LLC

  13. DDMS/RFID Takes Safety To “Pill Level” In Hospitals • “Real Time” monitoring of drug unit dose dispensing • Right drug, right time, right patient • Link data into patient file & billing • Compatible with overall RFID platform • Better inventory management (shelf life) • Deter theft DDMS,LLC

  14. Pharmaceutical Industry Facing Major Issues • Reduce clinical trial cost • Eliminate mistakes in hospitals • Implement track’n trace • Improve patient compliance DDMS/RFID packaging can provide solutions to all of these issues DDMS,LLC

  15. Improve Drug Supply Chain – Counterfeiting • Global Issue – 5-8% in US & growing • Billion $ impact on drug industry • Increased risk for consumers/patients getting low quality/adulterated drugs DDMS,LLC

  16. Pharmaceutical Supply Chain - Disjointed • 3 major distributors 80-90% • Remaining distributors are small • Regulated by states • Reselling common practice DDMS,LLC

  17. Improve Drug Supply Chain – Track'n Trace • FDA issues “compliance policy guide” • EPCglobal – Healthcare and Life Sciences Business Action Group • Successful 2004 eight month item level tagging test • HDMA supporting item level tagging goal = 2007 • Wal-Mart mandating class II tagging • Pedigree laws - Florida DDMS,LLC

  18. DDMS Takes RFID Item Tagging To Next Level • It is the more expensive drugs that are targets • DDMS provides a “security circuit” that can detect if a pill is removed • Opportunity to track’n trace to the “pill level” DDMS,LLC

  19. Pharmaceutical Industry Facing Major Issues • Reduce clinical trial cost • Eliminate mistakes in hospitals • Implement track’n trace • Improve patient compliance DDMS/RFID packaging can provide solutions to all of these issues DDMS,LLC

  20. Patient Compliance Biggest Healthcare Issue • Drains $100 billion/yr from economy • 10% of hospital admissions are due to non-compliance • 23% of nursing home admissions • Only 50% of patients follow doctors orders • Asthma, depression, high blood pressure • Drug industry loses $ billions in drug sales Source: World Health Organization & Healthcare Compliance Packaging Council DDMS,LLC

  21. Non-Compliance Problem Getting Worse • Major concern: “fear of side affects” • High cost of drugs • Preventive drugs require extended/life long regimen • Patients do not feel sick • We need new systems to help patient take their meds DDMS,LLC

  22. DDMS Provides Real Time Compliance Solution DDMS,LLC

  23. DDMS Advantages • Remind patients to take meds • Validates compliance – “real time” • Makes compliance data available to “stakeholders” • Cost effective solution for “post launch” trials DDMS,LLC

  24. DDMS Development Status • Establishing development partners • Expect first prototype 2005 • Initial commercial trials 2006-07 DDMS,LLC

  25. DDMS Patent Status • Three patents issued to date • July 2002 6,411,567 • June 2003 6,574,166 • Jan. 2005 6,839,304 • Additional pending US applications and corresponding foreign applications pending DDMS,LLC

  26. DDMS Could Be The “Silver Bullet” Solution • Reduce clinical trial cost • Eliminate mistakes in hospitals • Implement track’n trace – pill level • Significantly improve patient compliance DDMS,LLC

  27. For More Information About DDMS Reference: March/April Issue of RFID Product News article titled: “Pharma Focus: Driving Drug Delivery with RFID” Contact: Mark A. Niemiec President DDMS Holdings, LLC 904-543-1945 manpkg@aol.com DDMS,LLC

  28. “The Coming RFID Revolution in Individual Dose Drug Packaging” Mark A. Niemiec Global Packaging Innovations & DDMS Holdings June 6, 2005

More Related